MedKoo Cat#: 412903 | Name: Cimlanod
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cimlanod is an experimental drug for the treatment of acute decompensated heart failure. It was discovered by Cardioxyl Pharmaceuticals, which was acquired by Bristol-Myers Squibb. It is a nitroxyl donor. Cimlanod is a prodrug of CXL-1020.

Chemical Structure

Cimlanod
Cimlanod
CAS#1620330-72-4

Theoretical Analysis

MedKoo Cat#: 412903

Name: Cimlanod

CAS#: 1620330-72-4

Chemical Formula: C5H7NO4S

Exact Mass: 177.0096

Molecular Weight: 177.17

Elemental Analysis: C, 33.90; H, 3.98; N, 7.91; O, 36.12; S, 18.10

Price and Availability

Size Price Availability Quantity
1mg USD 250.00 2 Weeks
5mg USD 650.00 2 Weeks
10mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Cimlanod; CXL1427; CXL 1427; CXL-1427
IUPAC/Chemical Name
2-Furansulfonamide, N-hydroxy-5-methyl-
InChi Key
LIXKIXWSKOENAB-UHFFFAOYSA-N
InChi Code
InChI=1S/C5H7NO4S/c1-4-2-3-5(10-4)11(8,9)6-7/h2-3,6-7H,1H3
SMILES Code
O=S(C1=CC=C(C)O1)(NO)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 177.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Felker GM, McMurray JJV, Cleland JG, O'Connor CM, Teerlink JR, Voors AA, Belohlavek J, Böhm M, Borentain M, Bueno H, Cole RT, DeSouza MM, Ezekowitz JA, Filippatos G, Lang NN, Kessler PD, Martinez FA, Mebazaa A, Metra M, Mosterd A, Pang PS, Ponikowski P, Sato N, Seiffert D, Ye J. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study. JACC Heart Fail. 2020 Nov 24:S2213-1779(20)30590-4. doi: 10.1016/j.jchf.2020.10.012. Epub ahead of print. PMID: 33248986. 2: Greenberg B, Urey MA. Stand [Up] and Stand by for New Strategies for Treating Acute Heart Failure. JACC Heart Fail. 2020 Dec 24:S2213-1779(20)30636-3. doi: 10.1016/j.jchf.2020.11.001. Epub ahead of print. PMID: 33422436.